Skip to content

Comparison of the long-term efficacy of MIS-TLIF and Endo-LIF in the treatment of single-segment degenerative lumbar disease

Comparison of the long-term efficacy of MIS-TLIF and Endo-LIF in the treatment of single-segment degenerative lumbar disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043264
Enrollment
Unknown
Registered
2021-02-09
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar disease

Interventions

Group 2:Endo-LIF group

Sponsors

Jiangsu Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18 to 70 years; 2. Clinical symptoms are severe low back pain or low back pain, with or without intermittent claudication; 3. After 3-6 months of strict conservative treatment and ineffective; 4. The imaging manifestations are single-segment lumbar spondylolisthesis (degree I-II), lumbar spinal stenosis, and lumbar disc herniation, which are consistent with clinical symptoms; 5. Those who have no mental illness, can tolerate surgery and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with multi-level lumbar spine lesions judged by symptoms, signs, and imaging examinations; 2. Patients with a history of mental illness; 3. Patients with a history of lumbar spine surgery; 4. Patients with severe osteoporosis (dual energy T value measured by x-ray absorption method <= 2.5); 5. Patients with clear surgical contraindications, such as severe heart disease, diabetes, renal failure, respiratory failure, coagulopathy and other serious medical diseases; 6. Refusal to sign informed consent Patient.

Design outcomes

Primary

MeasureTime frame
VAS;ODI;Complications of each system;

Countries

China

Contacts

Public ContactLi Haijun

Jiangsu Taizhou People's Hospital

13901436563@163.com+86 13901436563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026